Biomarcadores de las Enfermedades Cardíacas
BIOMARCS
![Foto de Biomarcadores de las Enfermedades Cardíacas](/img/uploaded/e14fc215af57bf9a4f0f552bf7ec9db0.jpg)
![Foto de Howard Hughes Medical Institute](/img/noimage_org.png)
Howard Hughes Medical Institute
Chevy Chase, Estados UnidosPublications en collaboration avec des chercheurs de Howard Hughes Medical Institute (3)
2020
-
Hypertrophic cardiomyopathy in myosin-binding protein C (MYBPC3) Icelandic founder mutation carriers
Open Heart, Vol. 7, Núm. 1
2015
-
Diltiazem treatment for pre-Clinical hypertrophic cardiomyopathy sarcomereMutation carriers: A pilot randomized trial to modify disease expression
JACC: Heart Failure, Vol. 3, Núm. 2, pp. 180-188
2010
-
Myocardial fibrosis as an early manifestation of hypertrophic cardiomyopathy
New England Journal of Medicine, Vol. 363, Núm. 6, pp. 552-563